Skip to main content
Global Health Limited logo

Global Health Limited — Investor Relations & Filings

Ticker · MEDANTA ISIN · INE474Q01031 LEI · 335800TEDV7GWBKTVO07 BSE.NS Human health and social work activities
Open in API
Filings indexed 556 across all filing types
Latest filing 2026-05-23 Regulatory Filings
Country IN India
Listing BSE.NS MEDANTA

About Global Health Limited

https://www.medanta.org

Global Health Limited is a multi-specialty tertiary care provider operating under the Medanta brand. The organization delivers advanced medical services through a network of hospitals and clinics, focusing on quaternary care across complex specialties such as cardiology, oncology, neurosciences, digestive and hepatobiliary sciences, orthopaedics, and organ transplantation. Founded by Dr. Naresh Trehan, the company integrates clinical research with patient care, utilizing sophisticated medical technology including robotic-assisted surgical systems and advanced diagnostic tools. Its operational model emphasizes a comprehensive approach to healthcare, combining clinical excellence with academic initiatives. The service portfolio includes inpatient and outpatient care, emergency services, and specialized treatment programs designed to address high-acuity medical conditions through a multidisciplinary team of clinicians.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the year ended March 31 2026.
Regulatory Filings Classification · 93% confidence The document is an Annual Secretarial Compliance Report submitted under Regulation 24A of SEBI LODR, issued by the Company Secretary firm. It is a statutory compliance attestation rather than a full financial report, earnings release, management announcement, or board change. It serves as a regulatory filing/certificate of compliance, falling under the fallback category for miscellaneous regulatory submissions.
2026-05-23 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 90% confidence The document is an official disclosure to stock exchanges under SEBI Listing Regulations regarding the allotment of new equity shares under the company’s Employee Long Term Share Based Incentive Plan. It provides full details of the share issue, increased paid‐up capital, and complies with regulatory annexure requirements. This clearly constitutes a Share Issue/Capital Change announcement.
2026-05-23 English
Intimation under Regulation 30 of Listing regulations regarding Allotment of Shares.
Share Issue/Capital Change Classification · 98% confidence The document is an intimation to stock exchanges under SEBI Listing Regulations announcing the allotment of new equity shares under an employee stock option scheme, resulting in an increase in paid-up share capital. This is clearly a notification of a new share issue/capital change rather than a full report or earnings release. Therefore, it fits the Share Issue/Capital Change category (SHA).
2026-05-23 English
Intimation under SEBI Listing Regulations regarding Schedule of Analyst Meet.
Regulatory Filings Classification · 80% confidence The document is an intimation under SEBI (Listing Obligations and Disclosure Requirements) Regulation 30 notifying stock exchanges of upcoming one-to-one Analysts/Institutional Investor meetings. It is a regulatory disclosure notice rather than an earnings release, presentation, or financial report. It does not include any financial data or attach a formal report; it simply informs the exchanges of upcoming investor meetings. Accordingly, it is best classified as a general regulatory announcement (RNS).
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 78% confidence The document is an intimation sent to stock exchanges (BSE and NSE) under SEBI Listing Regulations (Regulation 30 read with Schedule III) notifying the schedule of management meetings with analysts/institutional investors. It contains no financial data, not a report itself, nor a presentation or earnings release. It is a regulatory announcement/compliance filing. Therefore, it fits the Regulatory Filings (RNS) category.
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 disclosure to stock exchanges informing about upcoming one‐to‐one meetings with analysts/institutional investors. It contains no financial statements, presentations, or voting results—merely a regulatory intimation under Reg 30. This fits the catch-all Regulatory Filings category (RNS).
2026-05-22 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.